Bioventus (BVS) Cash Flow: Operating & Free Cash Flow

Bioventus Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Bioventus Inc. (BVS) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 2025	Dec 2024	Dec 2023	Mar 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Operating Activities
Net Income	54.55	-94.10	-121.20	-144.65	-426.78	19.17	14.72	8.11	4.44
Depreciation & Amortization	47.01	49.56	57.37	55.40	55.40	34.88	28.64	30.32	29.24
Deferred Income Tax	0.00	-5.39	-2.38	-46.66	-46.66	-9.76	0.00	-0.35	-0.08
Stock Based Compensation	12.67	13.27	2.72	17.59	17.59	19.84	10.10	0.00	14.33
Change in Working Capital	-13.84	-11.78	-3.18	-29.73	-29.73	-15.15	15.31	-13.57	2.85
Change in Accounts Receivable	-0.92	-10.67	10.06	-17.67	-17.67	-20.05	0.00	-14.91	-12.13
Change in Inventory	8.57	-16.44	-5.99	-18.62	-18.62	3.18	0.00	-1.43	3.26
Change in Accounts Payable	-19.81	17.85	0.00	0.00	-3.10	18.21	0.00	6.65	12.15
Change in Other Working Capital	-1.68	4.23	2.43	6.56	1.49	-16.49	15.31	-3.88	-0.42
Other Operating Activities	1.56	4.23	2.43	134.52	1.49	-3.68	3.02	16.20	-5.59
Net Cash from Operating Activities	74.67	38.80	15.34	-13.54	-13.54	22.99	71.80	40.71	45.19
Investing Activities
Capital Expenditures	-2.56	-1.01	-7.36	-1.48	-1.48	-13.52	-20.67	-8.34	-6.06
Acquisitions	0.00	0.00	34.68	0.00	-104.84	-262.87	0.00	0.43	0.00
Purchases of Investments	0.00	0.00	0.00	0.00	-	-7.37	0.00	0.00	0.00
Sales/Maturities of Investments	0.00	-0.71	0.00	0.00	-	0.00	0.00	0.43	0.00
Other Investing Activities	-3.25	23.97	-11.51	-114.96	-104.84	-7.37	-3.92	-6.43	-0.04
Net Cash from Investing Activities	-3.25	22.96	15.81	-116.44	-116.44	-283.76	-20.50	-7.91	-6.10
Financing Activities
Debt Repayment	-74.82	-59.58	-87.26	59.62	-45.04	-91.25	-10.00	-1.37	-5.25
Common Stock Issued	2.07	2.44	0.78	5.82	5.82	109.41	0.00	0.00	0.00
Common Stock Repurchased	-0.01	0.00	0.00	0.00	-3.35	0.00	0.00	0.00	0.00
Dividends Paid	0.00	0.00	0.00	0.00	-	-0.37	-19.89	-9.14	-7.85
Other Financing Activities	-87.06	2.56	-4.17	-3.37	-3.37	-2.24	0.32	-0.45	-0.16
Net Cash from Financing Activities	-62.14	-54.58	-26.65	62.08	62.08	273.37	-29.57	-10.95	-13.26
Summary
Effect of Forex Changes on Cash	0.37	-2.56	0.63	0.52	0.52	-0.23	0.59	-0.10	-0.16
Net Change in Cash	9.66	4.62	5.13	-67.38	-67.38	12.37	22.32	21.75	25.67
Cash at Beginning of Period	41.58	36.96	31.84	99.21	99.21	86.84	64.52	42.77	17.10
Cash at End of Period	51.24	41.58	36.96	31.84	31.84	99.21	86.84	64.52	42.77
Free Cash Flow	72.11	37.79	7.98	-15.02	-15.02	9.47	51.13	32.37	39.13
Supplemental Disclosures
Interest Paid	-	38.51	32.47	-	18.04	5.84	7.49	-	-
Income Taxes Paid	-	1.34	2.96	-	1.52	7.46	1.54	-	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Bioventus Cash Flow

What is Bioventus's free cash flow?

Bioventus generated free cash flow of $72.11M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $74.67M minus $2.56M of capital expenditures. That was up 90.8% from $37.79M a year earlier. Free cash flow equaled 12.7% of revenue.

How much does Bioventus spend on capital expenditures?

Bioventus spent $2.56M on capital expenditures in fiscal 2025, compared with $1.01M a year earlier. That equals 3.4% of operating cash flow.

Does Bioventus pay dividends or buy back shares?

Yes. In fiscal 2025 Bioventus returned $9.00K in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition